Syra Health appoints Gregory R. Alexander as CEO effective Jan 5, 2026

Syra Health Corp

New CEO Gregory R. Alexander receives $251k base salary, 30% target bonus, and 110,537 RSUs.
Also granted 257,920 stock options (Class B) and 368,458 performance stock units.
Alexander previously served as SVP at Ellipsis Health, Chief Growth Officer at CitizensRx (tripled sales), and market leader at Lumeris (expanded from 3 to 11 markets).
He will replace interim CEO Priya Prasad; appointment follows an extensive national search.
Alexander is a former U.S. Marine Corps officer with over 20 years of P&L experience in healthcare.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.